Blood–Brain Barrier Leakage Is Increased in Parkinson’s Disease

Abstract

BackgroundBlood–brain barrier (BBB) disruption has been noted in animal models of Parkinson’s disease (PD) and forms the basis of the vascular hypothesis of neurodegeneration, yet clinical studies are lacking.ObjectiveTo determine alterations in BBB integrity in PD, with comparison to cerebrovascular disease.MethodsDynamic contrast enhanced magnetic resonance images were collected from 49 PD patients, 15 control subjects with cerebrovascular disease [control positive (CP)] and 31 healthy control subjects [control negative (CN)], with all groups matched for age. Quantitative maps of the contrast agent transfer coefficient across the BBB (Ktrans) and plasma volume (vp) were produced using Patlak analysis. Differences in Ktrans and vp were assessed with voxel-based analysis as well as in regions associated with PD pathophysiology. In addition, the volume of white matter lesions (WMLs) was obtained from T2-weighted fluid attenuation inversion recovery (FLAIR) images.ResultsHigher Ktrans, reflecting higher BBB leakage, was found in the PD group than in the CN group using voxel-based analysis; differences were most prominent in the posterior white matter regions. Region of interest analysis confirmed Ktrans to be significantly higher in PD than in CN, predominantly driven by differences in the substantia nigra, normal-appearing white matter, WML and the posterior cortex. WML volume was significantly higher in PD compared to CN. Ktrans values and WML volume were similar in PD and CP, suggesting a similar burden of cerebrovascular disease despite lower cardiovascular risk factors.ConclusionThese results show BBB disruption in PD.

The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?

“…Thus, the immune system has evolved to deal effectively with infection, however various genetic and other factors can conspire to result in inappropriate or chronic inflammation in response to altered proteins or self-antigens that manifests in autoimmune and inflammatory disease (131). Neuroinflammation associated with disorders such as Alzheimer's disease and PD attracts peripheral immune cells to the CNS, and the disruption of the BBB which is a pathological feature of these diseases means that there is a pathway for these cells to enter the brain parenchyma (132)(133)(134).…”

Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction

“…In addition, BBB leakage of fibrin and hemosiderin was observed in the striatum of PD patients ( Gray and Woulfe, 2015 ). Subtle BBB disruption in PD patients is observed in the substantia nigra, white matter and posterior cortical regions ( Al-Bachari et al, 2020 ).…”

The Common Neurological Presentations and Clinical Outcomes of Coronavirus Disease 2019 in Saudi Arabia

“…Previous studies found that SARS-COV-2 infection can either exacerbate pre-existing neurological disorders or complicate COVID-19 disease (20,21). Pre-existing neurological disorders, such as dementia, Parkinson disease, and stroke, are associated with a disrupted blood-brain barrier and vulnerability to infection and inflammatory states (22)(23)(24). SARS-COV-2 infection might reach the brain through olfactory nerves and other neurotropic or hematogenous routes (25).…”